List of Tables
Table 1. Kidney Fibrosis Treatment Market Trends
Table 2. Kidney Fibrosis Treatment Market Drivers & Opportunity
Table 3. Kidney Fibrosis Treatment Market Challenges
Table 4. Kidney Fibrosis Treatment Market Restraints
Table 5. Global Kidney Fibrosis Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Kidney Fibrosis Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Kidney Fibrosis Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Kidney Fibrosis Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Kidney Fibrosis Treatment
Table 10. Global Kidney Fibrosis Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Fibrosis Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Kidney Fibrosis Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Kidney Fibrosis Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Kidney Fibrosis Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Kidney Fibrosis Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Kidney Fibrosis Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Kidney Fibrosis Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Kidney Fibrosis Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Kidney Fibrosis Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Kidney Fibrosis Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Kidney Fibrosis Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Kidney Fibrosis Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Kidney Fibrosis Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Kidney Fibrosis Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Kidney Fibrosis Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Kidney Fibrosis Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Kidney Fibrosis Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Kidney Fibrosis Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Kidney Fibrosis Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Merck and Co(US) Basic Information List
Table 32. Merck and Co(US) Description and Business Overview
Table 33. Merck and Co(US) Kidney Fibrosis Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of Merck and Co(US) (2019-2024)
Table 35. Merck and Co(US) Recent Developments
Table 36. Pfizer Inc(US) Basic Information List
Table 37. Pfizer Inc(US) Description and Business Overview
Table 38. Pfizer Inc(US) Kidney Fibrosis Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of Pfizer Inc(US) (2019-2024)
Table 40. Pfizer Inc(US) Recent Developments
Table 41. F. Hoffman-La Roche(Switzerland) Basic Information List
Table 42. F. Hoffman-La Roche(Switzerland) Description and Business Overview
Table 43. F. Hoffman-La Roche(Switzerland) Kidney Fibrosis Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of F. Hoffman-La Roche(Switzerland) (2019-2024)
Table 45. F. Hoffman-La Roche(Switzerland) Recent Developments
Table 46. InterMune Inc(US) Basic Information List
Table 47. InterMune Inc(US) Description and Business Overview
Table 48. InterMune Inc(US) Kidney Fibrosis Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of InterMune Inc(US) (2019-2024)
Table 50. InterMune Inc(US) Recent Developments
Table 51. Galectin Therapeutics(US) Basic Information List
Table 52. Galectin Therapeutics(US) Description and Business Overview
Table 53. Galectin Therapeutics(US) Kidney Fibrosis Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of Galectin Therapeutics(US) (2019-2024)
Table 55. Galectin Therapeutics(US) Recent Developments
Table 56. La Jolla Pharmaceutical Company(US) Basic Information List
Table 57. La Jolla Pharmaceutical Company(US) Description and Business Overview
Table 58. La Jolla Pharmaceutical Company(US) Kidney Fibrosis Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of La Jolla Pharmaceutical Company(US) (2019-2024)
Table 60. La Jolla Pharmaceutical Company(US) Recent Developments
Table 61. ProMetic Life-Sciences Inc(Canada) Basic Information List
Table 62. ProMetic Life-Sciences Inc(Canada) Description and Business Overview
Table 63. ProMetic Life-Sciences Inc(Canada) Kidney Fibrosis Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of ProMetic Life-Sciences Inc(Canada) (2019-2024)
Table 65. ProMetic Life-Sciences Inc(Canada) Recent Developments
Table 66. BioLine Rx(Israel) Basic Information List
Table 67. BioLine Rx(Israel) Description and Business Overview
Table 68. BioLine Rx(Israel) Kidney Fibrosis Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of BioLine Rx(Israel) (2019-2024)
Table 70. BioLine Rx(Israel) Recent Developments
Table 71. Genzyme Corporation(US) Basic Information List
Table 72. Genzyme Corporation(US) Description and Business Overview
Table 73. Genzyme Corporation(US) Kidney Fibrosis Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Kidney Fibrosis Treatment Business of Genzyme Corporation(US) (2019-2024)
Table 75. Genzyme Corporation(US) Recent Developments
Table 76. Key Raw Materials Lists
Table 77. Raw Materials Key Suppliers Lists
Table 78. Kidney Fibrosis Treatment Downstream Customers
Table 79. Kidney Fibrosis Treatment Distributors List
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Kidney Fibrosis Treatment Product Picture
Figure 2. Global Kidney Fibrosis Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Kidney Fibrosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Kidney Fibrosis Treatment Report Years Considered
Figure 5. Global Kidney Fibrosis Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Kidney Fibrosis Treatment Revenue in 2023
Figure 7. Kidney Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Angiotensin Converting Enzyme (ACE) Inhibitors Picture
Figure 9. Pirfenidone Picture
Figure 10. Renin Inhibitors Picture
Figure 11. Angiotensin II Receptor Blockers (ARBs) Picture
Figure 12. Vasopeptidase Inhibitors Picture
Figure 13. Global Kidney Fibrosis Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Kidney Fibrosis Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Chronic Kidney Diseases
Figure 16. Product Picture of Kidney Cancer Treatment
Figure 17. Product Picture of Others
Figure 18. Global Kidney Fibrosis Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Kidney Fibrosis Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Kidney Fibrosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Kidney Fibrosis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Kidney Fibrosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Kidney Fibrosis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Kidney Fibrosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Kidney Fibrosis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Kidney Fibrosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Kidney Fibrosis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Kidney Fibrosis Treatment Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Kidney Fibrosis Treatment Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Kidney Fibrosis Treatment Sales Value (%), (2019-2030)
Figure 31. United States Kidney Fibrosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Kidney Fibrosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Kidney Fibrosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Kidney Fibrosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Kidney Fibrosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Kidney Fibrosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 37. China Kidney Fibrosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Kidney Fibrosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 39. China Kidney Fibrosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Kidney Fibrosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Kidney Fibrosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Kidney Fibrosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Kidney Fibrosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Kidney Fibrosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Kidney Fibrosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Kidney Fibrosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Kidney Fibrosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Kidney Fibrosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 49. India Kidney Fibrosis Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Kidney Fibrosis Treatment Sales Value by Type (%), 2023 VS 2030
Figure 51. India Kidney Fibrosis Treatment Sales Value by Application (%), 2023 VS 2030
Figure 52. Kidney Fibrosis Treatment Industrial Chain
Figure 53. Kidney Fibrosis Treatment Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
